Home / Drugs / anagrelide hydrochloride

anagrelide hydrochloride

FDA Drug Profile — Agrylin

Drug Details

Generic Name
anagrelide hydrochloride
Brand Names
Agrylin
Application Number
NDA020333
Sponsor
Takeda Pharmaceuticals America, Inc.
NDC Codes
2
Dosage Forms
CAPSULE, POWDER
Routes
ORAL
Active Ingredients
ANAGRELIDE HYDROCHLORIDE ANHYDROUS, ANAGRELIDE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE AGRYLIN is indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. AGRYLIN is a platelet reducing agent indicated for the treatment of thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. ( 1 )